NCT00955097

Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors

• Status: Terminated
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: University of Louisville · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of this study is to demonstrate the safety and effectiveness of using an intra-operative ultrasound contrast agent(Definity®) for the identification of known liver tumors.

Detailed description

The primary objective of this study is to demonstrate the safety of the use of intra-operative ultrasound contrast (Definity®) administration. The secondary objective of this study is to demonstrate the improved image quality and conspicuity of known liver tumors using contrast enhancement.

Conditions

• Liver Tumors

Interventions

Type	Name	Description
DRUG	Definity®	Definity® injections given both pre-ablation and post-ablation

Timeline

• Start date: 2008-05-01
• Primary completion: 2009-06-01
• Completion: 2010-05-01
• First posted: 2009-08-07
• Last updated: 2013-10-21

Locations

2 sites across 1 country: United States